COR

Add to Watchlist

Advanced Chart

0.000

0.000(0.000%)

Overview
Forecast
Valuation

Line

Candle

YTD

High

278.730

Open

275.970

VWAP

275.65

Vol

1.91M

Mkt Cap

54.85B

Low

271.000

Amount

525.49M

EV/EBITDA(TTM)

14.18

Total Shares

196.93M

60.90B

EV/OCF(TTM)

14.82

P/S(TTM)

0.18

Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company is focused on improving the lives of people and animals around the world. It is engaged in the delivery of pharmaceuticals, healthcare products, and solutions. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q1

FY2025Q4

FY2025Q3

86.67B

+6.36%

4.098

+9.87%

84.56B

+6.96%

3.833

+14.76%

80.25B

+8.1%

3.774

+13%

Estimates Revision

The market is revising Upward the revenue expectations for Cencora, Inc. (COR) for FY2025, with the revenue forecasts being adjusted by 0.22% over the past three months. During the same period, the stock price has changed by 12.21%.

Revenue Estimates for FY2025

Revise Upward

+0.22%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+0.48%

In Past 3 Month

Stock Price

Go Up

+12.21%

In Past 3 Month

10 Analyst Rating

12.68% Upside

Wall Street analysts forecast COR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for COR is 308.00 USD with a low forecast of 274.00 USD and a high forecast of 335.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

7 Buy

3 Hold

0 Sell

Moderate Buy

12.68% Upside

Current: 273.340

Low

274.00

Averages

308.00

High

335.00

12.68% Upside

Current: 273.340

Low

274.00

Averages

308.00

High

335.00

Baird

David Rodgers

Buy

Maintains

$314 → $350

2025-05-08

New

Reason

Baird

David Rodgers

Price Target

$314 → $350

2025-05-08

New

Maintains

Buy

Reason

Citigroup

Michael Rollins

Strong Buy

Maintains

$330 → $355

2025-05-08

New

Reason

Citigroup

Michael Rollins

Price Target

$330 → $355

2025-05-08

New

Maintains

Strong Buy

Reason

UBS

Kevin Caliendo

Strong Buy

Maintains

$298 → $335

2025-04-29

Reason

UBS

Kevin Caliendo

Price Target

$298 → $335

2025-04-29

Maintains

Strong Buy

Reason

UBS raised the firm's price target on Cencora to $335 from $298 and keeps a Buy rating on the shares.

B of A Securities

Michael Funk

Hold

Maintains

$270 → $285

2025-04-11

Reason

B of A Securities

Michael Funk

Price Target

$270 → $285

2025-04-11

Maintains

Hold

Reason

Wells Fargo

Stephen Baxter

Hold

Maintains

$251 → $274

2025-03-14

Reason

Wells Fargo

Stephen Baxter

Price Target

$251 → $274

2025-03-14

Maintains

Hold

Reason

Wells Fargo raised the firm's price target on Cencora to $274 from $251 and keeps an Equal Weight rating on the shares. The firm is updating its model following Cencora's results and more recent guidance raise. Estimates for all years move higher based on U.S. strength, partially offset by lower International vs. Wells' previous model.

Evercore ISI Group

John Belton

Buy

Maintains

$270 → $280

2025-02-06

Reason

Evercore ISI Group

John Belton

Price Target

$270 → $280

2025-02-06

Maintains

Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Cencora Inc (COR.N) is 17.13, compared to its 5-year average forward P/E of 13.76. For a more detailed relative valuation and DCF analysis to assess Cencora Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Overvalued

5Y Average PE

13.76

Current PE

17.13

Overvalued PE

15.75

Undervalued PE

11.78

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Overvalued

5Y Average EV/EBITDA

9.98

Current EV/EBITDA

12.69

Overvalued EV/EBITDA

11.56

Undervalued EV/EBITDA

8.41

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Overvalued

5Y Average PS

0.13

Current PS

0.17

Overvalued PS

0.15

Undervalued PS

0.11

Financials

Annual

Quarterly

FY2025Q2

YoY :

+10.29%

75.45B

Total Revenue

FY2025Q2

YoY :

+13.90%

1.02B

Operating Profit

FY2025Q2

YoY :

+70.32%

717.42M

Net Income after Tax

FY2025Q2

YoY :

+76.08%

3.68

EPS - Diluted

FY2025Q2

YoY :

-425.08%

3.22B

Free Cash Flow

FY2025Q2

YoY :

+4.20%

3.47

Gross Profit Margin - %

FY2025Q2

YoY :

+51.32%

1.15

FCF Margin - %

FY2025Q2

YoY :

+53.23%

0.95

Net Margin - %

FY2025Q2

YoY :

-28.83%

24.78

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

13.2M

USD

3-6

Months

316.6M

USD

6-9

Months

27.7M

USD

0-12

Months

4.9M

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

0-3

Months

0.0

Volume

3-6

Months

138.3K

Volume

6-9

Months

0.0

Volume

0-12

Months

444.6K

Volume

Bought

0-3

0.0

Volume

Months

3-6

42.2K

Volume

Months

6-9

0.0

Volume

Months

0-12

110.5K

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

65.0K

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

115.5K

USD

Months

0-12

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

13.2M

USD

3-6

Months

316.6M

USD

6-9

Months

27.7M

USD

0-12

Months

4.9M

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

COR News & Events

Events Timeline

2025-05-12 (ET)

2025-05-12

10:59:57

New

White House publishes Trump executive order aimed at lowering drug prices

2025-05-12

10:28:47

New

Trump says will 'cut out middlemen' to reduce drug prices

2025-05-12

10:25:01

New

Trump says will 'cut out middlemen' to reduce drug prices

News

1.0

05-09Globenewswire

Metals and Mining Virtual Investor Conference: Presentations Now Available for Online Viewing

2.0

05-08MarketWatch

Cencora Inc. stock underperforms Thursday when compared to competitors

4.0

05-08Benzinga

Citigroup Maintains Buy on Cencora, Raises Price Target to $355

People Also Watch

CPSS

Consumer Portfolio Services Inc

Alta Equipment Group Inc

Alliance Entertainment Holding Corp

Lexicon Pharmaceuticals Inc

DiaMedica Therapeutics Inc

Eagle Point Income Company Inc

Nautilus Biotechnology Inc

0.732

USD

+4.57%

FAQ

What is Cencora Inc (COR) stock price today?

The current price of COR is 273.34 USD — it has decreased -3.41 % in the last trading day.

COR

Market Estimates

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Trading Trends

COR News & Events

Events Timeline

News

People Also Watch

FAQ

What is Cencora Inc (COR) stock price today?

What is Cencora Inc (COR)'s business?

What is the price predicton of COR Stock?

What is Cencora Inc (COR)'s revenue for the last quarter?

What is Cencora Inc (COR)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Cencora Inc (COR)'s fundamentals?

How many employees does Cencora Inc (COR). have?

What is Cencora Inc (COR) market cap?